Poultry Vaccines Market Report 2026

The poultry vaccines market size has grown strongly in recent years. It will grow from $1.94 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to outbreaks of avian diseases, rising poultry consumption, development of traditional vaccines, increasing farm-level veterinary awareness, expansion of commercial poultry farming.

The poultry vaccines market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growth of recombinant and dna vaccines, adoption of precision poultry vaccination programs, technological advancements in vaccine delivery systems, government initiatives for poultry health, increasing focus on biosecurity measures in poultry farms. Major trends in the forecast period include adoption of live and inactivated poultry vaccines, focus on disease prevention in broilers and layers, expansion of recombinant and dna vaccine usage, integration of vaccination programs with farm management practices, development of cold chain infrastructure for poultry vaccine distribution.

The rising prevalence of zoonotic diseases is expected to drive the growth of the poultry vaccine market in the coming years. Zoonotic diseases are illnesses caused by pathogenic microorganisms such as viruses, bacteria, parasites, and fungi that can be transmitted between animals and humans. Their increasing prevalence is linked to greater human-animal interaction, as urban expansion and livestock farming bring people and animals into closer proximity. The poultry vaccine market supports this trend, as heightened disease risks create the need for vaccinations to prevent the transmission of infections from poultry to humans and to maintain flock health. For example, in December 2025, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, the five most reported zoonoses in humans in 2024 were campylobacteriosis, with 168,396 cases (55.3 per 100,000 people); salmonellosis, with 79,703 cases (18.6 per 100,000 people); Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 per 100,000 people); and echinococcosis, with 984 cases (0.22 per 100,000 people). Therefore, the growing prevalence of zoonotic diseases is expected to propel the poultry vaccine market.

Key players in the poultry vaccine market are concentrating on developing new technological solutions to enhance their market position. These solutions include advanced vaccine formulations, delivery systems, and diagnostic tools designed to improve disease prevention, vaccine efficacy, and poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company, launched CircoMax, a porcine circovirus type 2 (PCV2) vaccine covering two genotypes, a and b. The vaccine aims to protect against PCV2 risks, including the three genotypes present in the UK pig herd, offering broader coverage. CircoMax is the only licensed PCV2 vaccine to provide protection against PCV2a, PCV2b, and PCV2d, demonstrating high efficacy, convenience, and proven safety while helping Zoetis stay ahead of PCV2 genotype evolution.

In July 2025, Vaxxinova NV, a Netherlands-based animal health company offering vaccines and immunization solutions for livestock and poultry, acquired Deltamune (Pty) Ltd for an undisclosed amount. Through this acquisition, Vaxxinova aims to strengthen and expand its vaccine research, development, and production capabilities in the African livestock market while broadening its global footprint and portfolio of animal health solutions. Deltamune (Pty) Ltd, based in South Africa, specializes in the development, manufacture, and distribution of licensed and autogenous vaccines and healthcare products for livestock, serving markets across Sub-Saharan Africa.

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the poultry vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the poultry vaccine market by increasing the cost of imported vaccines, production equipment, and cold chain logistics. Segments like live, recombinant, and DNA vaccines are most impacted, particularly in regions such as North America, Europe, and Asia-Pacific, where import reliance is high. Although tariffs raise operational costs, they may encourage local manufacturing, support domestic innovation, and improve the supply of regionally produced vaccines.

The poultry vaccines market research report is one of a series of new reports that provides poultry vaccines market statistics, including poultry vaccines industry global market size, regional shares, competitors with a poultry vaccines market share, detailed poultry vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the poultry vaccines industry. This poultry vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Poultry vaccines, on the other hand, are immunizations administered to prevent and control diseases in poultry animals. These vaccinations play a crucial role in the poultry industry, particularly in chicken production, by aiming to enhance productivity through the prevention or limitation of clinical diseases at the farm level.

Poultry vaccines come in various types, including porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others. Porcine vaccines, a subset of poultry vaccines, involve the use of a high-pressure injector for immunizing pigs. This injector disperses 0.1 to 0.5 milliliters of the vaccination dosage. Porcine vaccines are applied to combat different diseases such as avian influenza and infectious bronchitis, requiring various dosage forms such as liquid vaccines, freeze-dried vaccines, and duct vaccines. Technologies involved in poultry vaccines encompass toxoid, live attenuated vaccines, recombinant vaccines, and inactivated vaccines, which are applied in broiler, layer, and breeder poultry.

The poultry vaccine market consists of revenues earned by entities by providing poultry vaccine services such as poultry health management, vaccination to poultry ducks, vaccination knowledge management, trainings. The market value includes the value of related goods sold by the service provider or included within the service offering. The poultry vaccine market also includes sales of chicken farm equipment, vaccination syringe, drugs, needle gun which are used in providing poultry vaccine services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.